HTA Co., Ltd.

8 clinical trials · Sponsor

Record	Firm	Date
A Clinical Study Evaluating the Diagnostic Performance and Safety of PET for the Deposition of Aβ Plaques in the Brain of Participants With Normal Cognitive Function, MCI and AD Using [18F]Fluorbetazine Injection (NCT07764679)	HTA Co., Ltd.	2025-06-20
Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer (NCT06754085)	HTA Co., Ltd.	2024-12-19
Evaluate the Diagnostic Efficacy, Pharmacokinetics and Safety of 68Ga-DOTATATE Injection PET/CT in NETs (NCT07119242)	HTA Co., Ltd.	2024-01-08
Technetium Tc 99m Sulfur Colloid Injection for Tracing Sentinel Nodes in Breast Cancer (NCT07764653)	HTA Co., Ltd.	2024-01-02
A Phase III Clinical Study to Compare the Safety and Efficacy of 177Lu-DOTATATE Injection and Long-acting Oxytrexine in Adult Patients With NETs (NCT07057622)	HTA Co., Ltd.	2023-12-12
A Phase I Clinical Study on the Safety and Pharmacokinetics of [18F]Florbetazine Injection (NCT06593626)	HTA Co., Ltd.	2023-11-06
Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer (NCT06011304)	HTA Co., Ltd.	2023-10-20
Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases Compared With 99mTc⁃MDP-BS±SPECT (NCT05614518)	HTA Co., Ltd.	2021-03-29

Every clearance here is in the API, with alerts when new ones post.